Change text here Change text here Change text here Change text here Change text here Change text here
Our Platform
Two Platforms. One Target: CD161+ T Cells
LNP/mRNA Platform
A lipid nanoparticle delivers mRNA that triggers disease-causing T cells to self-destruct — precisely, in vivo, in one step.
Antibody Platform
A targeting antibody recruits the body's own immune cells to seek out and clear those same disease-causing T cells.
